A study has found that patients with ischemic stroke and COVID-19, compared with patients without COVID-19, experience worse recovery outcomes.

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

Pegloticase therapy for uncontrolled gout does not appear to significantly increase the risk for cardiovascular (CV) or thromboembolic (TE) events, despite the potential for increased gout flares ...

The use of menopausal hormone therapy is associated with an increased risk of developing SLE and SSc among women.

Higher calcium intake is associated with reduced colorectal cancer risk across tumor sites and calcium sources.

Selarsdi (ustekinumab-aekn; Teva and Alvotech), and Yesintek (ustekinumab-kfce; Biocon Biologics), all biosimilars to Stelara (ustekinumab; Johnson & Johnson) are now available in the US.

Postpandemic hospital occupancy higher than prepandemic and expected to continue increasing without changes in staffed hospital bed supply.

There is evidence for epidural steroid injections reducing pain and disability in cervical and lumbar radiculopathies.